Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001326190-25-000066
Filing Date
2025-11-06
Accepted
2025-11-06 16:25:38
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B5 alt-20251106x424b5.htm 424B5 401053
2 GRAPHIC alt-20251106x424b5001.jpg GRAPHIC 10085
3 GRAPHIC alt-20251106x424b5005.jpg GRAPHIC 12083
4 GRAPHIC alt-20251106x424b5007.jpg GRAPHIC 70088
5 GRAPHIC alt-20251106x424b5008.jpg GRAPHIC 134691
6 GRAPHIC alt-20251106x424b5009.jpg GRAPHIC 12108
  Complete submission text file 0001326190-25-000066.txt   732305
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

EIN.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-285355 | Film No.: 251458791
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)